Thalidomide for the treatment of refractory necrobiosis lipoidica

Arch Dermatol. 2006 Jan;142(1):20-2. doi: 10.1001/archderm.142.1.20.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Necrobiosis Lipoidica / drug therapy*
  • Thalidomide / therapeutic use*

Substances

  • Angiogenesis Inhibitors
  • Thalidomide